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Abstract
As the scope and complexity of synthetic biology grows, an under­
standing of evolution and ecology will be critical to its success.
One of the most powerful and controversial aspects of 
engineer ing living organisms is that they reproduce, 
evolve, and interact with their environment. Humans have 
been engineering plants and animals since the advent of 
agriculture approximately 12,000 years ago through breed­
ing and artificial selection for their domestication [1]. The 
evolution of corn from the small grass teosinte [2], or the 
transformation of the wolf into ‘man’s best friend’ (the 
dog) [1] are testaments to the success of this approach. We 
have even ‘domesticated’ microorganisms, using yeast and 
bacteria for the production of beer, wine, cheese and 
yogurt as well as numerous other products we consume 
every day [3,4].
Although powerful, genetic engineering by classical breed­
ing and selection is slow, and results in a large number of 
unknown genetic changes that are hard to reconcile and 
may have unintended secondary effects. What we need is a 
rational approach to the engineering of biological systems 
that makes the process fast, cheap and safe, to solve 
problems in energy, health, agriculture and the environ­
ment. First steps towards realizing this aim began with the 
advent of recombinant DNA technology in the latter half of 
the 20th century, which created visions of a new era of 
‘synthetic biology’ where novel genes could be designed 
and constructed for useful purposes [5­7]. Since then we 
have made incredible advances in our ability to manipulate 
genes, genomes and organisms, and this has led to a 
renewed interest in making synthetic biology a reality [8].
A number of recent reviews have been written on the 
principles and practice of synthetic biology [8­11], but here 
we focus on the interplay between synthetic biology, 
evolution and ecology. Evolution teaches us about what 
solutions nature has evolved for biological problems, how 
to evolve them further, and how robust they are to change. 
Ecology gives us information on how our engineered 
systems will perform once they leave the laboratory and 
enter an industrial bioreactor (a vessel or tank used for the 
controlled growth of microorganisms) or the natural 
environment. As the scope and complexity of synthetic 
biology grows, we argue that an understanding of evolution 
and ecology is critical to its success. We have explored 
some of these ideas in the past [12­14], but here we focus 
on four practical lessons that serve as a starting point for 
integrating evolutionary and ecological concepts into 
synthetic biology research and practice (Figure 1).
Lesson 1: Evolution is a source of functional 
diversity and modularity
One of the central goals of synthetic biology is to develop 
genetic elements with encapsulated functions, such as 
regulatory circuits or environmental sensors, that can be 
combined to create new pathways with predictable behav­
iours. Despite our ability to synthesize genes and even 
genomes [15], we still lack the sophistication to design de 
novo those genetic elements needed for advanced synthetic 
biology applications. Fortunately, evolution has already 
provided us with an immense diversity of biomolecular 
functions that can be used individually or combined by 
putting together natural functional modules.
Bacteria and archaea represent perhaps the largest reser­
voirs of new genes and new biochemical functions that can 
be harnessed by the synthetic biologist. Current estimates 
of the number of bacterial species range from 1 million to 
as many as 1 billion [16,17], each representing a unique 
genetic solution to the environmental challenges posed by 
diverse ecological niches. This incredible diversity of 
species in turn encodes a vast universe of protein functions. 
As of October 2009, there were 11,912 protein families in 
the Pfam database alone [18,19]. Despite this large 
number, our sampling of protein function is still incom­
plete, and many new activities still remain to be discovered 
in nature [20]. In addition, there is probably a vast array of 
non­coding RNA functions and DNA regulatory sequences 
that would serve as useful genetic elements for synthetic 
biology but which are difficult to detect by typical 
sequencing methods because of their fast rate of evolution.
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This plethora of gene functions derived from evolution has 
not gone unnoticed, and it has been standard practice in 
genetic engineering to mix and match genes from many 
organisms. One driving force behind this has been to make 
bacteria such as Escherichia coli into ‘chemical factories’ 
for the production of drugs, fine chemicals and other 
commercially important compounds. Recent successes 
include the production of amorpha­4,11­diene (a precursor 
of the antimalarial drug artemisinin) [21], the production 
of putrescine (used for the production of the plastic nylon­
4,6) [22] and the production of 4­hydroxyvalerate (which 
can be converted into polyesters and other plastics) [23]. 
Along with other examples, such as the production of the 
amino acids l­valine [24] and l­threonine [25] from 
engineered bacteria, such successes have founded a field of 
metabolic engineering that strives to leverage the meta­
bolic flexibility of microbes to convert simple inputs such 
as sugars to desirable complex compounds [11,26]. For 
many applications, the gene function or enzymatic chemis­
try is already available in nature, but if not, there are 
experimental strategies that can circumvent this problem 
(see Lesson 2).
Even if a gene function exists in nature, our ability to use it 
to engineer complex biological systems with new composite 
functions relies on the modularity inherent in naturally 
evolved systems. Modular biological systems are composed 
of functional domains that can be individually swapped or 
altered to change the overall characteristics of the system. 
Examples of modularity in biology abound at nearly all 
scales, and include basic gene regulation elements (promo­
ters and binding sites for transcription factors), protein 
domains, macromolecular protein complexes, and cellular 
regulatory networks [27­31]. A number of compelling 
studies have demonstrated that modularity in biological 
systems arises under selection in a changeable environ­
ment [32,33], and modularity seems to have been selected 
because it makes ‘rewiring’ on an evolutionary timescale 
more effective [34]. The ability to rewire natural biological 
systems makes nature a vast source of modular ‘parts’ for 
the synthetic biologist. However, we must be careful to 
obey the rules of modularity and domain boundaries that 
nature uses. Understanding these rules, at both the 
molecular and organismal levels, is currently an active area 
of research [35­37].
Lesson 2: Evolutionary mechanisms can be 
exploited to improve synthetic designs
As discussed above, evolution has provided a vast universe 
of genes and factorable modules that can be harnessed by 
the synthetic biologist to engineer new biological systems. 
In the simplest scenario, the desired function can be used 
‘as is’ without any further modification. However, many 
synthetic designs require that we modify or tweak a gene 
function, such as altering an enzyme activity or changing a 
regulatory element. In extreme cases we need a gene 
function or activity that does not actually exist in nature. 
For example, incorporation of unnatural amino acids (for 
example, p­boronophenylalanine) into proteins is now 
possible using tRNA synthetases created in the laboratory 
and this enables the site­specific modification of proteins 
using boronate­based chemistry [38]. Enzymes that 
catalyze the Kemp elimination reaction have been pro­
duced by using a combination of computational protein 
design and molecular evolution (see below) [39].
Fortunately, a suite of experimental techniques exists that 
can create new gene function in the laboratory on the basis 
of a deep understanding of the fundamental mechanisms 
of evolutionary change ­ variation by mutation and 
recombination, differential reproduction and heredity. 
These so­called ‘in vitro evolution’ methods have been 
applied successfully to DNA, RNA and proteins [40­44]. 
Like classical breeding and artificial selection, they are 
iterative processes, involving rounds of library creation, 
screening and selection. Here, we focus on the library­
creation step because it has benefited most from our 
knowledge of evolutionary mechanisms. The traditional 
approach to library creation involves generating random 
Figure 1
Ecological forces drive evolution, which in turn influences ecologies. 
This cycle creates a diverse array of functions that can be used in 
synthetic designs. Individual functions may be combined and 
evolved in the laboratory to create new synthetic systems that may 
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variation, for which there are a number of standard 
methods such as random DNA synthesis, error­prone PCR, 
chemical mutagenesis or the use of mutator strains.
Random mutagenesis by itself is inefficient, and computer 
simulations of evolution have demonstrated that a low 
level of point mutation plus recombination is an optimal 
strategy for creating diversity [45]. This observation led to 
the development of gene shuffling, which is a powerful 
technique for the rapid evolution of protein function [44]. 
In this process, random DNA fragmentation and reassem bly 
by PCR is used to simulate recombination in the laboratory. 
Gene shuffling has been used to increase enzyme activity 
[46], alter substrate specificity [47] and improve the 
properties of green fluorescent protein [48].
Gene shuffling has been further expanded to genome shuf­
fling, which combines mutagenesis with protoplast fusion 
to rapidly evolve microbes for the purpose of strain 
improvement [49]. Because multiple advantageous muta­
tions may be combined during each round of mutagenesis 
and protoplast fusion, genome shuffling has proved 
superior to classical methods for strain improvement (that 
is, mutagenesis plus selection); however, it still suffers 
from the limitation that the genetic basis for the improve­
ment is not known. Most recently, a method for rapid 
genome engineering in bacteria has been developed, called 
multiplexed automated genome engineering (MAGE), that 
allows at least 20 directed genomic mutations at once by 
using mutagenic oligos [50]. The combination of MAGE, 
genome shuffling and the means to vary the selection 
pressure to enable bouts of random mutation without 
selection (that is, neutral evolution) [51] might be a 
powerful approach to the more rapid evolution of strains 
with desired characteristics. This method could be applied 
to developing strains with increased metabolic flux through 
an engineered pathway, or to improve tolerance to environ­
mental stresses, such as pH or temperature. The take­
home lesson is that evolutionary mechanisms have 
provided a powerful set of experimental tools for the rapid 
engineering of biological function. As we continue to 
under stand how natural systems evolve, we can further 
exploit these processes for engineering genes and genomes 
in the laboratory.
Ultimately, even laboratory evolution is not sufficient for 
the engineering of complex biological systems. As designs 
become more complex, directed evolution at multiple 
genetic loci starts to resemble classical breeding and 
selection ­ where we do not understand the connection 
between genotype and phenotype. Furthermore, these 
evolution­based strategies require that we have selections 
or screens for the desired traits, which rapidly becomes too 
difficult as we move beyond the simplest applications. We 
envisage that synthetic biologists will use a hybrid 
approach starting with rational design using modular parts 
(Lesson 1), followed by organism­level evolution around 
the designed genetic architecture of the system for final 
optimization [52].
Lesson 3: Optimal designs need to be 
insulated from evolution
Even though we may use evolution as a tool to create novel 
function and optimize designs, we must be aware that its 
driving force for change does not stop when we deploy a 
system in a bioreactor or in the environment. Once a 
system is ready for use we would like to halt evolution, or 
at least minimize it, so that our system can perform 
without diverging from its original specifications. All the 
mechanisms of evolutionary change that were exploited to 
develop our system now need to be counteracted. This is 
quite a challenge and requires a focus on the two main 
sources of evolutionary change in nature ­ horizontal gene 
transfer (HGT) and random mutation.
One strategy for minimizing evolution is to prevent HGT. 
HGT can occur in three ways: by conjugation, transduction 
or transformation [53]. Conjugation is the transfer of 
genetic material (often a plasmid) between bacteria 
through direct cell­to­cell contact. Many plasmids encode 
their own mobilization and transfer functions and can 
move between bacteria by conjugation. In the early days of 
recombinant DNA research it was recognized that these 
plasmid sequences could be deleted, thus preventing their 
transfer [54]. In addition, cell­envelope proteins that are 
necessary for conjugation can be mutated.
By contrast, transduction and transformation enable trans fer 
of DNA without cell contact. Transduction is mediated by 
bacteriophages whereas transformation is the uptake of 
free DNA from the environment. Transduction can be 
prevented by mutating a wide­range of bacteriophage 
receptors to give phage­resistant strains. Ideally, we could 
develop broad­range phage resistance, and there is 
evidence that such mutations exist. In one example, three 
mutants of Streptococcus thermophilus were identified 
that were resistant to 14 phages after screening for resis­
tance to just one lytic phage, Sfi19 [55]. Other strategies for 
broad­range phage resistance could include engineering 
the CRISPR (clustered, regularly interspaced, short palin­
dromic repeat) genes, which have recently been hypothe­
sized to be a bacterial ‘immune system’ that targets the 
degradation and silencing of foreign DNA [56].
The third mechanism of HGT involves natural transfor­
mation, and one strategy to prevent this is to mutate com 
genes and thus prevent uptake of DNA from the 
environment [57]. Competence (com) genes encode a set of 
proteins that are localized in the bacterial cell envelope and 
are critical for processing and uptake of DNA. If all else 
fails and foreign DNA does get inside the cell of an 
engineered strain it could be prevented from integrating 
114.4
http://genomebiology.com/2009/10/11/114 Skerker et al.: Genome Biology 2009, 10:114
into the genome by using a rec­ strain background or by 
installing a strong restriction/modification system. Recom­
bi nation (rec) genes are essential for homologous recombi­
nation, so a rec- strain would not be able to recombine the 
foreign DNA into its chromosome. Restriction/modifica­
tion systems degrade incoming DNA that is not specifically 
‘marked’ by methylation by the host bacterium, and so 
would block HGT before the recombination step.
A second strategy for minimizing evolution is to modulate 
the mutation rate. Defects in the mismatch repair system, 
for example, dramatically increase the mutation rate. The 
mismatch repair system recognizes mispaired nucleotides 
that arise during errors in DNA replication and recom­
bination and recruits the necessary enzymes to repair the 
mistake. Many of these genes were first identified as 
mutator (mut) genes, which led to an increase in mutation 
frequency when deleted. For example, loss of function of 
mutS or mutL leads to a 102­ to 103­fold increase in the 
frequency of transition and frameshift mutations [58]. By 
contrast, overexpression of MutS or MutL leads to a 
decrease in the mutation frequency, and this could be one 
strategy for minimizing evolution [59]. This study 
suggested that other genes might exist that increase the 
mutation rate when overexpressed. In this regard, a 
multicopy genetic screen in E. coli identified 15 loci that 
when overexpressed led to a mutator­like phenotype, and 
12 of these were previously uncharacterized [60]. In 
theory, every mechanism that nature uses to increase the 
mutation rate could be reversed by overexpression or 
deletion of the appropriate genes, although this general 
idea remains to be tested.
Lesson 4: Engineered systems should 
minimize disruption of ecologies
At present, the cutting­edge of genetic manipulation is in 
metabolic engineering [21,22,50]. The bacterium E. coli 
has long been a workhorse in this field, largely because of 
its ease of genetic manipulation and the large amount of 
knowledge and resources accumulated. However, when we 
start to consider applications of synthetic biology beyond 
the bioreactor, such as bioremediation or therapeutic use 
in the human body, we must consider the complex nature 
of these environments. In particular, we must ensure that 
our engineered biological system works to specification 
without unintended disruptions to the natural ecology of 
the environment or human host, and that it can be easily 
identified and removed if necessary.
Bioremediation is the use of living organisms to return an 
ecosystem to its natural state after toxic contamination. 
Ever since the advent of recombinant DNA technology, the 
use of genetically modified (GM) organisms for bio­
remedia tion has been a holy grail. Unfortunately, most 
attempts at using GM bacteria for bioremediation have 
failed because the engineered strain had reduced fitness 
and competed poorly with indigenous microbial commu­
nities [61]. Although E. coli is a natural choice for use as a 
chemical factory in a laboratory bioreactor, it makes no 
sense to engineer a bacterium that normally resides in the 
human gut for bioremediation of a toxic­waste site. It is 
more appropriate to engineer organisms that are derived 
directly from the target ecology. This is not without its 
challenges, however.
The industrial chemical 2­chlorotoluene is produced in 
large amounts and is used in a variety of consumer 
products. It is toxic to aquatic environments and humans, 
is inert to chemical hydrolysis in environmental conditions, 
and is therefore an interesting target for microbial 
bioremediation. Initial attempts at engineering soil­
derived Pseudomonas species for 2­chlorotoluene degrada­
tion [62] failed because of the complex nature of environ­
mental influences on gene regulation [61]. Given the tools 
of synthetic and systems biology, there is renewed hope 
that such problems, which are due to strong coupling of 
engineered organisms to target ecologies, can now be 
overcome.
One of the principal areas that needs development is the 
characterization of organisms for use in different 
bioremediation applications. This will mean identifying the 
key organisms responsible for the biotransformation 
process of interest, isolating and culturing their commu­
nities in the laboratory so they can be engineered for 
enhanced bioremediation and ecological stabilization, and 
then reintroducing them into the environment. Although 
there will be many difficulties in implementing this 
strategy, metagenomic techniques have greatly advanced 
the identification of the complex microbial communities 
that exist in the environment [63]. Recent work also shows 
that we now have the technology to manipulate previously 
genetically intractable systems: the complete genome of 
Mycoplasma mycoides was transferred into yeast, altered 
using yeast genetic tools, and then transplanted back into a 
Mycoplasma cell to yield a new M. mycoides strain [64].
When considering the ‘real­world’ applications of synthetic 
biology such as bioremediation the environmental impact 
and safety of the engineered organisms are important 
considerations. Introducing an engineered organism into a 
bioremediation site can be thought of as purposefully 
introducing an invasive species. Whether it is successful 
and competes with the native organisms depends on its 
relative fitness and its ability to evolve and adapt to its 
environment [65]. Even though these engineered strains 
may be less fit and perhaps even less effective than the 
native species, they have the advantage that they can be 
engineered with a ‘leash’ or other system to prevent their 
unwanted spread. Such safeguards have been in place since 
the beginning of recombinant DNA research, and have 
been further developed over the years [66­68].
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One worry is that engineered strains will evolve around 
introduced safeguards, and Lesson 3 highlights ways in 
which we might address this possibility. Even so, the DNA 
of the engineered system could still be released after cell 
death and could be taken up by other bacteria in the 
ecosystem by natural transformation. How can we prevent 
the spread of engineered DNA by this route? If we could 
engineer strains that use an alternative genetic code, then 
even if the DNA gets transferred into other bacteria, 
translation would produce a functionless protein. This 
would similarly prevent ‘natural’ DNA accidentally 
imported into the engineered organism from being 
expressed. Alternative genetic codes exist in mitochondria 
and ciliates [69], and there are many examples of artificial 
alternative codes based on the tRNA synthetase system first 
developed by Schultz and co­workers [70]. There are even 
translation systems that work orthogonally to the natural 
host system, and that would not function in bacteria that did 
not have the correct ribosomal apparatus [71].
The interplay between synthetic biology, 
evolution and ecology
Whatever the strategy we choose to follow to prevent 
unwanted spread, understanding the interplay between 
ecology and synthetic biology is critical to predicting how 
an engineered system might evolve in and interact with a 
natural environment. Once we take our engineered system 
out of the laboratory, whether into an industrial fermen­
tation tank, the environment (for example, bioremediation) 
or a human host (for example, a therapeutic organism), we 
need to understand how our design will evolve according to 
the selective pressures of its environment, and how it will 
affect the ecology of its environment. The synthetic 
biologist is constantly in a state of tension ­ on one hand, 
exploiting the mechanisms of evolution to engineer more 
complex biological systems, and on the other trying to keep 
the design robust to evolution once it is released. Once 
introduced into the environment, the engineered biological 
system also needs to ‘play well with others’ and not 
adversely disrupt the natural ecology. There are complex 
considerations, both ethical and legal, in releasing 
genetically modified bacteria into the environment for 
study or application [72] or even in disclosing the tech­
nology that enables the engineering of organisms able to 
survive in the outside world. However, having a deeper 
understanding of the interplay between evolution, ecology 
and synthetic biology will be critical in moving our designs 
‘beyond the bioreactor’ into the real world where they can 
safely and effectively benefit society.
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